Upregulation of fibronectin and the α5β1 and αvβ3 integrins on blood vessels within the cerebral ischemic penumbra

Experimental Neurology

Volumn 233, Issue 1, 2012, Pages 283-291

  Li, Longxuan ^a   Liu, Fudong ^b   Welser Alves, Jennifer V ^a   McCullough, Louise D ^b   Milner, Richard ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Angiogenesis; Astrocyte; Cerebral ischemia; Endothelial cells; Fibronectin; Integrin; Laminin

Indexed keywords

ALPHA6 INTEGRIN; CD31 ANTIGEN; DYSTROGLYCAN; FIBRONECTIN; KI 67 ANTIGEN; LAMININ; VERY LATE ACTIVATION ANTIGEN 5; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; BRAIN ISCHEMIA; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HYPOXIA; IMMUNOFLUORESCENCE TEST; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REPERFUSION;

ANIMALS; ANTIGENS, CD31; BLOOD VESSELS; BRAIN ISCHEMIA; CELL DEATH; DISEASE MODELS, ANIMAL; DYSTROGLYCANS; FIBRONECTINS; FUNCTIONAL LATERALITY; GLIAL FIBRILLARY ACIDIC PROTEIN; IN SITU NICK-END LABELING; INTEGRIN ALPHA5BETA1; INTEGRIN ALPHAVBETA3; KI-67 ANTIGEN; MACROPHAGE-1 ANTIGEN; MALE; MICE; MICE, INBRED C57BL; NERVOUS SYSTEM DISEASES; UP-REGULATION;

EID: 84856217220     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.10.017     Document Type: Article

References (45)

1. Astrof S., Hynes R.O. Fibronectins in vascular development. Angiogenesis 2009, 12:165-175.
2. Bader B., Rayburn H., Crowley D., Hynes R. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins. Cell 1998, 95:507-519.
3. Chavez J.C., Agani F., Pichiule P., LaManna J.C. Expression of hypoxic inducible factor 1α in the brain of rats during chronic hypoxia. J. Appl. Physiol. 2000, 89:1937-1942.
4. Chen H.H., Chien C.H., Liu H.M. Correlation between angiogenesis and basic fibroblast growth factor expression in experimental brain infarct. Stroke 1994, 25:1651-1657.
5. Chen Y., Xu B., Arderiu G., Hashimoto T., Young W.L., Boudreau N.J., Yang G.Y. Retroviral delivery of homeobox D3 gene induces cerebral angiogenesis in mice. J. Cereb. Blood Flow Metab. 2004, 24:1280-1287.
6. del Zoppo G.J., Hallenbeck J.M. Advances in the vascular pathophysiology of ischemic stroke. Thromb. Res. 2000, 98:V73-V81.
7. Dirnagl U., Iadecola C., Moskowitz M.A. Pathophysiology of ischemic stroke: an integrated view. Trends Neurosci. 1999, 22:391-397.
8. Dummula K., Vinukonda G., Xu H., Hu F., Zia M.T., Braun A., Shi Q., Wolk J., Ballabh P. Development of integrins in the vasculature of germinal matrix, cerebral cortex, and white matter of fetuses and premature infants. J. Neurosci. Res. 2010, 88:1193-1204.
9. Engelhardt B., Conley F.K., Butcher E.C. Cell adhesion molecules on vessels during neuroinflammation in the mouse central nervous system. J. Neuroimmunol. 1994, 51:199-208.
10. George E.L., Georges-Labouesse E.N., Patel-King R.S., Rayburn H., Hynes R.O. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 1993, 119:1079-1091.
11. Greenberg D.A., Jin K. From angiogenesis to neuropathology. Nature 2005, 438:954-959.
12. Hallman R., Mayer D.N., Berg E.L., Broermann R., Butcher E.C. Novel mouse endothelial cell surface marker is suppressed during differentiation of the blood brain barrier. Dev. Dyn. 1995, 202:325-332.
13. Hamann G.F., Okada Y., Fitridge R., del Zoppo G.J. Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. Stroke 1995, 26:2121-21266.
14. Hamann G.F., Okada Y., del Zoppo G.J. Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia. J. Cereb. Blood Flow Metab. 1996, 16:1373-1378.
15. Hanisch U.K., Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 2007, 10:1387-1394.
16. Hayashi T., Noshita N., Sugawara T., Chan P.H. Temporal profile of angiogenesis and expression of related genes in the brain after ischemia. J. Cereb. Blood Flow Metab. 2003, 23:166-180.
17. Janzer R.C., Raff M.C. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 1987, 325:253-257.
18. Johnston S.C., Rothwell P.M., Nguyen-Huynh M.N., Giles M.F., Elkins J.S., Bernstein A.L., Sidney S. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007, 369:283-292.
19. Kim S., Bell K., Mousa S.A., Varner J.A. Regulation of angiogenesis in vivo by ligation of integrin a5b1 with the central cell-binding domain of fibronectin. Am. J. Pathol. 2000, 156:1345-1362.
20. Krupinski J., Kaluza J., Kumar P., Kumar S., Wang J.M. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 1994, 25:1794-1798.
21. Kuo N.-T., Benhayon D., Przybylski R.J., Martin R.J., LaManna J.C. Prolonged hypoxia increases vascular endothelial growth factor mRNA and protein in adult mouse brain. J. Appl. Physiol. 1999, 86:260-264.
22. Lathia J.D., Chigurupati S., Thundyil J., Selvaraj P.K., Mughal M.R., Woodruff T.M., Chan S.L., Karamyan V.T., Mattson M.P., Arumugam T.V. Pivotal role for beta-1 integrin in neurovascular remodelling after ischemic stroke. Exp. Neurol. 2010, 221:107-114.
23. Li J., Zeng Z., Viollet B., Ronnett G.V., McCullough L.D. Neuroprotective effects of adenosine monophosphate-activated protein kinase inhibition and gene deletion in stroke. Stroke 2007, 38(11):2992-2999.
24. Li L., Welser J.V., Milner R. Absence of the αvβ3 integrin dictates the time-course of angiogenesis in the hypoxic central nervous system: accelerated endothelial proliferation correlates with compensatory increases in α5β1 integrin expression. J. Cereb. Blood Flow Metab. 2010, 30:1031-1043.
25. Liu F., Schafer D.P., McCullough L.D. TTC, Fluro-Jade B and NeuN staining confirm evolving phases of infarction induced by middle cerebral artery occlusion. J. Neurosci. Methods 2009, 179:1-8.
26. McCullough L.D., Zeng Z., Li H., Landree L.E., McFadden J., Ronnett G.V. Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke. J. Biol. Chem. 2005, 280(21):20493-20502.
27. Milner R., Campbell I.L. Developmental regulation of β1 integrins during angiogenesis in the central nervous system. Mol. Cell. Neurosci. 2002, 20:616-626.
28. Milner R., Hung S., Erokwu B., Dore-Duffy P., LaManna J.C., del Zoppo G.J. Increased expression of fibronectin and the α5β1 integrin in angiogenic cerebral blood vessels of mice subject to hypobaric hypoxia. Mol. Cell. Neurosci. 2008, 38:43-52.
29. Milner R., Hung S., Wang X., Spatz M., del Zoppo G. The rapid decrease in astrocyte-associated dystroglycan expression by focal cerebral ischemia is protease-dependent. J. Cereb. Blood Flow Metab. 2008, 28:812-823.
30. Okada Y., Copeland B.R., Hamann G.F., Koziol J.A., Cheresh D.A., del Zoppo G.J. Integrin αvβ3 is expressed in selective microvessels following focal cerebral ischemia. Am. J. Pathol. 1996, 149:37-44.
31. Pichiule P., LaManna J.C. Angiopoietin-2 and rat brain capillary remodeling during adaptation and de-adaptation to prolonged mild hypoxia. J. Appl. Physiol. 2002, 93:1131-1139.
32. Risau W., Lemmon V. Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. Dev. Biol. 1988, 125:441-450.
33. Rothwell P.M., Giles M.F., Flossmann E., Lovelock C.E., Redgrave J.N., Warlow C.P., Mehta Z. A simple score (ABCD) to identify individuals at high risk of early stroke after transient ischaemic attack. Lancet 2005, 366:29-36.
34. Sakai T., Johnson K.J., Murozono M., Sakai K., Magnuson M.A., Wieloch T., Cronberg T., Isshiki A., Erickson H.P., Fassler R. Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia bit is not essential for skin-wound healing and hemostasis. Nat. Med. 2001, 7:324-330.
35. Sharp F.R., Lu A., Tang Y., Millhorn D.E. Multiple molecular penumbras after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 2000, 20:1011-1032.
36. Tagaya M., Liu K.F., Copeland B.R., Seiffert D., Engler R., Garcia J.H., del Zoppo G.J. DNA scission after focal brain ischemia. Temporal differences in two species. Stroke 1997, 28:1245-1254.
37. Tagaya M., Haring H.-P., Stuiver J., Wagner S., Abumiya T., Lucero J., Lee P., Copeland B., Seiffert D., del Zoppo G. Rapid loss of microvascular integrin expression during focal brain ischemia reflects neuron injury. J. Cereb. Blood Flow Metab. 2001, 21:835-846.
38. Tate C.A., Garcia A.J., LaPlaca M.C. Plasma fibronectin is neuroprotective following traumatic brain injury. Exp. Neurol. 2007, 207:13-22.
39. Tonnesen M.G., Jenkins D., Siegal S.L., Lee L.A., Huff J.C., Clark R.A. Expression of fibronectin, laminin, and factor VIII-related antigen during development of the human cutaneous microvasculature. J. Invest. Dermatol. 1985, 85:564-568.
40. Wagner S., Tagaya M., Koziol J., Quaranta V., del Zoppo G.J. Rapid disruption of an astrocyte interaction with the extracellular matrix mediated by integrin α6β4 during focal cerebral ischemia/reperfusion. Stroke 1997, 28:858-865.
41. Wei L., Erinjeri J.P., Rovainen C.M., Woolsey T.A. Collateral growth and angiogenesis around cortical stroke. Stroke 2001, 32:2179-2184.
42. Yang J.T., Rayburn H., Hynes R.O. Embryonic mesodermal defects in α5 integrin-deficient mice. Development 1993, 119:1093-1105.
43. Yang J.T., Rayburn H., Hynes R.O. Cell adhesion events mediated by α4 integrins are essential in placental and cardiac development. Development 1995, 121:549-560.
44. Yang Y., Estrada E.Y., Thompson J.F., Liu W., Rosenberg G.A. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J. Cereb. Blood Flow Metab. 2007, 27:697-709.
45. Zhang Z.G., Zhang L., Jiang Q., Zhang R., Davies K., Powers C., Bruggen N.V., Chopp M. VEGF enhances angiogenesis and promoted blood-brain barrier leakage in the ischemic brain. Clin. Investig. 2000, 106:829-838.